Making strides to treat the unknown: carcinoma of unknown primary

Does access to prior mammograms improve the performance of radiographers in interpreting screening mammograms?

Radiography (London, England : 1995)·2024

Access to prior screening mammograms affects the specificity but not sensitivity of radiologists' performance.

Clinical radiology·2024

First Measurement of the Nuclear-Recoil Ionization Yield in Silicon at 100 eV.

Physical review letters·2023

Source-detector trajectory optimization in cone-beam computed tomography: a comprehensive review on today's state-of-the-art.

Physics in medicine and biology·2022

Constraints on Lightly Ionizing Particles from CDMSlite.

Physical review letters·2021

Light Dark Matter Search with a High-Resolution Athermal Phonon Detector Operated above Ground.

Physical review letters·2021

Predictive validity of a 10-item frailty index based on a comprehensive geriatric assessment (FI-CGA-10) in older Japanese adults with cancer.

Journal of the National Cancer Institute·2026

Association between genomic classifier scores and initial management of localized prostate cancer in the United States.

Journal of the National Cancer Institute·2026

Timing of mental disorders in relation to cancer-specific mortality in cancer patients.

Journal of the National Cancer Institute·2026

Addressing the impact of tobacco and alcohol use on cancer-related health outcomes.

Journal of the National Cancer Institute·2026

Epigenetic aging of colorectal mucosa in cancer development.

Journal of the National Cancer Institute·2026

Randomized trial of adjuvant 5-FU-platinum vs paclitaxel-platinum for high-risk penile cancer.

Journal of the National Cancer Institute·2026

EGFR kinase inhibitors from novel thiazole derivatives: synthesis, anticolon cancer, docking, and ADME studies.

Future medicinal chemistry·2026

Beyond the ceiling: A critical analysis of microRNA research in cutaneous T-cell lymphoma and a roadmap forward.

The Journal of investigative dermatology·2026

Tumor-Secreted ADAMTSL4 Activates Latent TGFβ1 to Drive Cancer Cachexia.

Cancer discovery·2026

Epigenetic Repression of Type I Interferon Signaling by RUNX2 Drives Immune Checkpoint Blockade Resistance in Osteosarcoma.

Cancer research·2026

The Trispecific Antibody IBI3019 Integrates CDH17-Enhanced EGFR Antagonism with Optimized CD16A Engagement to Elicit Potent Antitumor Activity with Minimal Toxicity.

Cancer research·2026

Targeting glutaminase (GLS) to suppress CXCL8 secretion and sensitize esophageal squamous cell carcinoma to immunotherapy.

Journal of chemotherapy (Florence, Italy)·2026

Related Experiment Videos

Making strides to treat the unknown: carcinoma of unknown primary

Related Concept Videos

Does access to prior mammograms improve the performance of radiographers in interpreting screening mammograms?

Access to prior screening mammograms affects the specificity but not sensitivity of radiologists' performance.

First Measurement of the Nuclear-Recoil Ionization Yield in Silicon at 100 eV.

Source-detector trajectory optimization in cone-beam computed tomography: a comprehensive review on today's state-of-the-art.

Constraints on Lightly Ionizing Particles from CDMSlite.

Light Dark Matter Search with a High-Resolution Athermal Phonon Detector Operated above Ground.

Predictive validity of a 10-item frailty index based on a comprehensive geriatric assessment (FI-CGA-10) in older Japanese adults with cancer.

Association between genomic classifier scores and initial management of localized prostate cancer in the United States.

Timing of mental disorders in relation to cancer-specific mortality in cancer patients.

Addressing the impact of tobacco and alcohol use on cancer-related health outcomes.

Epigenetic aging of colorectal mucosa in cancer development.

Randomized trial of adjuvant 5-FU-platinum vs paclitaxel-platinum for high-risk penile cancer.

EGFR kinase inhibitors from novel thiazole derivatives: synthesis, anticolon cancer, docking, and ADME studies.

Beyond the ceiling: A critical analysis of microRNA research in cutaneous T-cell lymphoma and a roadmap forward.

Tumor-Secreted ADAMTSL4 Activates Latent TGFβ1 to Drive Cancer Cachexia.

Epigenetic Repression of Type I Interferon Signaling by RUNX2 Drives Immune Checkpoint Blockade Resistance in Osteosarcoma.

The Trispecific Antibody IBI3019 Integrates CDH17-Enhanced EGFR Antagonism with Optimized CD16A Engagement to Elicit Potent Antitumor Activity with Minimal Toxicity.

Targeting glutaminase (GLS) to suppress CXCL8 secretion and sensitize esophageal squamous cell carcinoma to immunotherapy.

Related Experiment Videos

Making strides to treat the unknown: carcinoma of unknown primary

Related Concept Videos

Related Articles